Transrectal ultrasound-guided biopsy of the prostate: Relation between ASA use and bleeding complications

Canadian Association of Radiologists Journal

Volumn 50, Issue 3, 1999, Pages 173-176

  Herget, Eric J ^a   Saliken, John C ^b,c   Donnelly, Brian J ^b   Gray, Robin R ^b   Wiseman, David ^b   Brunet, Grant ^b  

^a FOOTHILLS HOSPITAL   (Canada)

^b Rockyview Hospital   (Canada)

^c Mission Centre   (Canada)

Author keywords

ASA; Biopsy; Bleeding; Complications; Nonsteroidal anti inflammatory drugs; Prostate

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN; SULFINPYRAZONE; THROMBOXANE A2; WARFARIN;

ADULT; ARTICLE; BIOPSY TECHNIQUE; BLEEDING TENDENCY; CLINICAL ARTICLE; DIAGNOSTIC APPROACH ROUTE; DISEASE ASSOCIATION; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; PROSTATE BIOPSY; RISK ASSESSMENT; TRANSRECTAL ULTRASONOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; ASPIRIN; BIOPSY, NEEDLE; ENDOSONOGRAPHY; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE HEMORRHAGE; PROSPECTIVE STUDIES; PROSTATE; PROSTATIC NEOPLASMS; RECTUM; RISK FACTORS;

EID: 0032765714     PISSN: 00082902     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Nornberg M. Transrectal ultrasound and core biopsies for the diagnosis of prostate cancer. A study of pretreatment investigation strategy for patients with suspected prostate cancer. Acta Radiol Suppl 1994;393:1-21.
2. Hammerer P, Huland H. Systematic sextant biopsies in 651 patients referred for prostate evaluation. J Urol 1994;151:99-102.
3. Enlund AL, Varenhorst E. Morbidity of ultrasound-guided transrectal core biopsy of the prostate without prophylactic antibiotic therapy. A prospective study of 415 cases. Br J Urol 1997;79:777-780.
4. Collins GN, Lloyd SN, Hehir M, McKelvie GB. Multiple transrectal ultrasound-guided prostatic biopsies - true morbidity and patient acceptance. Br J Urol 1993;71:460-463.
5. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1997. CA Cancer J Clin 1997;47(1):5-27.
6. Miller BA, Ries LA, Hankey BF. Cancer statistics review 1973-1989. NIH publication 92-2789. Bethesda (MD): National Cancer Institute; 1992.
7. Mettlin CJ, Murphy GP, McGinnis LS, Menck HR. The national cancer data base report on prostatic cancer. American college of surgeons commission on cancer and the American Cancer Society. Cancer 1995; 76:1104-1112.
8. Mettlin CJ, Murphy GP, Cunningham MP, Menck HR. The National Cancer data base report on longitudinal observations on prostate cancer. Cancer 1996;77:2162-2166.
9. Steinberg GD, Carter BS, Beaty TH, Childs B, Walsh PC. Family history and the risk of prostate cancer. Prostate 1990;17(1):337-347.
10. Gronberg H, Damber L, Damber JE. Familial prostate cancer in Sweden: a nationwide register cohort study. Cancer 1996; 77(1): 138-143
11. Shiffman ML, Farrel MT, Yee YS. Risk of bleeding after endoscopic biopsy or polypectomy in patients taking aspirin or other NSAIDS. Gastrointest Endosc 1994;40(4): 458-462.
12. Gazelle GS, Haaga JR, Rowland DY. Bleeding due to needle biopsy: effect of venopirin in an animal model and implications for humans. J Vasc Interv Radiol 1993; 4(2):305-310.
13. O'Laughlin JC, Hoftiezer JW, Mahoney JP, Ivey KJ. Does aspirin prolong bleeding from gastric biopsies in man? Gastrointest Endosc 1981; 27(1):1-5.
14. Roth SH. Non-steroidal anti-inflammatory drugs, gastrophy, deaths and medical practice. Ann Intern Med 1988;109:353-354.